Patent details

EP3303619 Title: PD-L1 PROMOTER METHYLATION IN CANCER

Basic Information

Publication number:
EP3303619
PCT Application Number:
US2016034856
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167285253
PCT Publication Number:
WO2016196381
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PD-L1 PROMOTER METHYLATION IN CANCER
French Title of Invention:
MÉTHYLATION DE PROMOTEUR DE PD-L1 DANS LE CANCER
German Title of Invention:
PD-L1-PROMOTORMETHYLIERUNG BEI KREBS
SPC Number:

Dates

Filing date:
27/05/2016
Grant date:
10/06/2020
EP Publication Date:
11/04/2018
PCT Publication Date:
08/12/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/06/2020
EP B1 Publication Date:
10/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/05/2021
Expiration date:
27/05/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/06/2020
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:
WALTER, Kimberly
Address:
United States (US)

2

Name:
KOWANETZ, Marcin
Address:
United States (US)

3

Name:
KADEL, Edward
Address:
United States (US)

Priority

Priority Number:
201562168668 P
Priority Date:
29/05/2015
Priority Country:
United States (US)

Classification

IPC classification:
C12Q 1/6886;

Publication

European Patent Bulletin

Issue number:
202024
Publication date:
10/06/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages